Genmont Biotech reports Sep revenue NT$45.6M vs NT$31.0M
Genmont Biotech Inc. reported September revenue of NT$45.578M versus NT$31.026M, and Jan-Sep revenue of NT$295.934M versus NT$300.525M, per Taiwan Stock Exchange figures.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.